Asian Cancer Institute

What Asian Cancer Institute does

Asian Cancer Institute (ACI), operating as Asian Institute of Oncology Pvt Ltd, is a privately held Indian multi-specialty hospital chain headquartered in Mumbai with a focused positioning in oncology. Founded in 2002 by senior surgical oncologists from Tata Memorial Hospital, including Padma Shri awardee Dr. Ramakant Deshpande, the group operates a flagship 50+ bed NABH-accredited tertiary hospital at Cumballa Hill (Mumbai, since January 2020) and a 104-bed super specialty facility in Indore (soft-launched November 2023). Clinical operations span surgical oncology, medical oncology, precision oncology (with genetic counselling), radiation therapy, and parallel multi-specialty services including cardiology, cardiovascular and thoracic surgery, orthopaedics and joint replacement, plastic and reconstructive surgery, laparoscopic/laser/robotic surgery, gynaecology, internal medicine, diagnostics, and pharmacy.

The technology stack comprises robotic surgery suites, modular operating theaters with laminar airflow and HEPA filtration, interventional radiology (embolization, radiofrequency ablation, venous access), advanced imaging, and an AI-assisted cardiology platform with low-dose technology. Service-level technology differentiators include precision oncology with tumor DNA analysis and an in-house diagnostics lab offering immunohistochemistry with 135+ markers and molecular biology/cytogenetics. ACI's revenue model is fee-for-service across inpatient stays (tiered room charges from Rs. 2,500/day general ward to Rs. 9,900/day suite), surgeries, chemotherapy, radiation, diagnostics, pharmacy, and preventive health packages, with cashless access enabled through partnerships with major insurers and TPAs (ICICI Lombard, HDFC Ergo, Aditya Birla Health, Paramount, FHPL, United Health, Vidal) and empanelment under CGHS, MJPJAY, and GIPSA.

ACI is executing an aggressive multi-city expansion strategy with announced or in-progress facilities in Virar, Pune (majority acquisition of a 125-bed cancer hospital), Bhubaneswar (NCLT IBC acquisition of Hemalata Hospitals), Kolkata (200-bed greenfield on acquired land), and Srinagar (collaboration with Florence Hospital), targeting 1,000 beds within 2 years and 5,000 beds within 10 years. Group CEO Dr. Rahul Bajpai (appointed December 2022, previously COO of HCG for almost a decade) leads the scaling effort. The chain is founder/physician-led with no disclosed institutional capital or external PE/VC ownership.

Name

Asian Cancer Institute

Legal name

Asian Institute of Oncology Pvt Ltd

Website

https://asiancancerinstitute.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Asian Cancer Institute is a privately held Indian multi-specialty hospital chain, founded in 2002 by Tata Memorial Hospital oncologists, focused on oncology (surgical, medical, precision) and complementary specialties across hospitals in Mumbai and Indore, with an aggressive multi-city expansion underway.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (62211), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Surgical Oncology (HLAKAFAG)

Keywords

• Cancer treatment services
• Multi-specialty hospital
• Oncology care
• Surgical oncology
• Precision oncology

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Patient Services: Core revenue from patient care services including consultations, surgeries, chemotherapy, radiation therapy, diagnostic tests, and inpatient stays across multiple specialties
2. Diagnostic Services: Revenue from laboratory tests, imaging services (X-ray, ultrasound, mammography), pathology, and specialized diagnostic procedures
3. Inpatient Ward/ Room Charges: Bed charges and accommodation fees across various room categories from Standard General Ward to Suite rooms
4. Pharmacy Services: 24x7 pharmacy services providing medications and medical products to inpatients and outpatients
5. Health Packages: Preventive health check-up packages and screening programs

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Asian Cancer Institute operates a chain of multi-specialty hospitals in India offering comprehensive cancer care (surgical oncology, medical oncology, chemotherapy, radiation therapy, precision oncology) alongside supporting specialties including cardiology, orthopaedics, internal medicine, and advanced diagnostics. Revenue is generated through inpatient and outpatient hospital services, surgical procedures, diagnostic tests, pharmacy, and preventive health packages at hospital locations in Mumbai, Indore, and planned cities.

Product overview

Asian Cancer Institute operates as a chain of multi-specialty hospitals with super specialty oncology services. The organization offers a comprehensive healthcare platform combining core cancer care services (Surgical Oncology, Medical Oncology, Precision Oncology) with supporting specialties (Cardiology, Orthopedics, Internal Medicine, Plastic Surgery). Key product offerings include specialized surgical procedures (Laparoscopic, Laser, Robotic surgery), advanced diagnostic services (Radiology, Laboratory, Endoscopy), and patient support services (Pharmacy, Emergency, Physiotherapy, Clinical Nutrition). The institute provides dedicated facilities like the Breast Clinic and Daycare Center for Chemotherapy, offering treatment from diagnosis through rehabilitation across hospital locations in Mumbai and Indore.

Differentiator

Problem solved

Functional benefit

Products and services

• Surgical Oncology Specialized cancer surgery focusing on tumor removal and adjacent tissue/organ resection, including biopsies, curative surgery, staging surgery, preventive surgery, supportive surgery, reconstructive surgery, and palliative care. Offers open surgery and minimally invasive techniques including laparoscopy, laser surgery, and cryosurgery for cancer patients.
• Medical Oncology Clinical and experimental research for cancer diagnosis, treatment, and prevention. Involves administering chemotherapy for solid tumors and hematological malignancies, including targeted and biological therapies.
• Precision Oncology Individualized cancer treatment using genetic testing to analyze tumor DNA and create tailored treatment plans targeting specific mutations and proteins, offered as the most affordable precision oncology service in South Mumbai with free genetic counselling.
• Cardiology Diagnosis and treatment of cardiovascular diseases including angiography, angioplasty, pacemaker implantation, and TAVI (transcatheter aortic valve implantation) procedures supported by an AI-based cardiology platform with low dose technology.
• Cardiovascular & Thoracic Surgery Surgical treatment for heart and chest conditions including open heart surgery, bypass surgery, heart valve procedures, and treatment for lung and esophageal cancers.
• Orthopaedic & Joint Replacement Musculoskeletal care including knee and hip replacement, spine surgery, onco-orthopedics, arthroscopy, ligament reconstruction, sports orthopedics, and trauma care, with robotic and minimally invasive procedures available.
• Internal Medicine Comprehensive adult medical care including chronic illness management, acute care, diagnosis, treatment, and preventative healthcare.
• Plastic & Reconstructive Surgery Restorative surgery for cancer patients including facial reconstruction after tumor removal and breast reconstruction after mastectomy, with support for post-radiation and chemotherapy patients.
• Radiology & Imaging State-of-the-art imaging services including X-ray, ultrasound, mammography, 2D echo, and interventional radiology procedures such as embolization and radiofrequency ablation.
• Diagnostics & Laboratory 24x7 laboratory services including blood tests, immunity tests, immunohistochemistry with 135+ markers, and molecular biology/cytogenetics testing for oncology and general diagnostics.
• Pharmacy Services 24x7 pharmacy services with comprehensive drug procurement, e-prescriptions, inventory management, and coverage of oncology medications for inpatients and outpatients.
• Emergency Services 24x7 emergency medical care with dedicated team, operation theatres, radiology, pharmacy, and laboratory services for acute and trauma cases.
• Breast Clinic Specialized breast health evaluation and treatment including self-examination training, mammogram referrals, ultrasound scans, and biopsies for accurate diagnosis of breast conditions.
• Preventive Health Packages Preventive health check-up packages and screening programs covering cancer screening and general wellness assessments for early detection and prevention.
• Endoscopy Services Advanced endoscopic procedures including gastroscope, duodenoscope, enteroscope, colonoscope, endoscopic ultrasound (EUS), and ERCP for gastrointestinal diagnosis and treatment.

Quantifiable outcome

• Targeting 1000 beds in next 2 years and 5000 beds in 10 years
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered expansion and acquisition.

• Florence Hospital, SrinagarexpansionStrategic or Co-development PartnerCollaborative agreement with Florence Hospital in Srinagar for setting up a world class comprehensive cancer center with state-of-the-art radiation therapy and PET CT facilities
• NCLT IBC - Hemalata Hospitals, BhubaneswaracquisitionStrategic or Co-development PartnerAcquired through NCLT IBC process, Hemalata Hospitals located in prime location of Bhubaneswar, Odisha. Clinical operations expected to start by July 2024.
• Onco-surgeons Group, PuneexpansionStrategic or Co-development PartnerACI signed term sheet for acquiring majority stake in a 125 Bed operational Cancer Hospital in Pune managed by a group of top onco-surgeons of Pune

Scale indicators7 records

Recent moves14 records

Expansion highlights6 records

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AsianCancerInst
• YouTubeyoutube.com/channel/UCgdo0VQeAp3V0TvCRyVG-3Q
• Facebookfacebook.com/AsianCancerInstitute
• LinkedInlinkedin.com/school/3666869/admin/dashboard
• Instagraminstagram.com/aci_india

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asian Cancer Institute